The Europe Protein Chip Market is expected to witness market growth of 8.69% CAGR during the forecast period (2021-2027).
Proteomics refers to the protein expression profiling under which proteins are determined in the lysate of a specific cell. In addition, protein functional analysis includes the recognition of protein-protein interactions, small molecule targets, protein–phospholipid interactions, enzymatic substrates, especially the substrates of kinases, and receptor ligands. Antibody characterization refers to the identification of specificity, cross-reactivity, and mapping epitopes. In addition, treatment development includes the making of antigen-specific therapies for cancer, autoimmunity, and allergies; the recognition of little molecule targets, which can possibly be utilized as new drugs.
The strong healthcare infrastructure of various nations in the region is one of the crucial factors bolstering the growth of the regional Protein Chip Market.
Additionally, the rising prevalence of chronic diseases, especially cancer is creating the demand for Protein Chip Markets in the regional market. It is because Protein Chip Markets help in the diagnosis of cancer. These chips can be customized by the manufacturers as per the requirements of the customers and provide high effectiveness and reliability. Due to this, the demand for Protein Chip Markets is expected to increase in the region over the forecast period.
The Germany market dominated the Europe Protein Chip Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $77.1 million by 2027. The UK market is anticipated to grow at a CAGR of 7.6% during (2021 - 2027). Additionally, The France market is expected to witness a CAGR of 10% during (2021 - 2027).
Based on End User, the market is segmented into Pharmaceuticals and Biotechnology Sector, Academic & Research Institutes, Diagnostic Laboratories and Hospitals and Clinics. Based on Technology, the market is segmented into Analytical Microarrays, Functional Protein Microarrays and Reverse Phase Protein Microarrays. Based on Application, the market is segmented into Diagnostics, Proteomics and Antibody Characterization. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., RayBiotech Life, Inc., Quotient limited, Danaher Corporation, Arrayit Corporation, Merck Group, and Illumina, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Pharmaceuticals and Biotechnology Sector
- Academic & Research Institutes
- Diagnostic Laboratories and
- Hospitals and Clinics
By Technology
- Analytical Microarrays
- Functional Protein Microarrays and
- Reverse Phase Protein Microarrays
By Application
- Diagnostics
- Proteomics and
- Antibody Characterization
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- RayBiotech Life, Inc.
- Quotient limited
- Danaher Corporation
- Arrayit Corporation
- Merck Group
- Illumina, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific, Inc.
- RayBiotech Life, Inc.
- Quotient limited
- Danaher Corporation
- Arrayit Corporation
- Merck Group
- Illumina, Inc.
Methodology
LOADING...
